CHICAGO – Weill Cornell Medicine has received a two-year, $1.5 million grant from the National Institutes of Health to study ethnic, social, and biological factors — including a heavy dose of genomics — that might predict severity and outcomes of big-city patients with COVID-19. The New York City academic medical center will seek to uncover the role of genetics and social determinants of health in disparities in COVID-19 progression and mortality.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.